China provides free COVID-19 vaccines for all citizens!
- Subversive discovery: Can lymph nodes promote the success of cancer immunotherapy?
- Major Discovery: Cancer cell PD-L1 does not inhibit T cell toxicity
- The new coronavirus may kill cancer cells and achieve a permanent cure!
- Why did the Alzheimer’s drug candidate BACE1 inhibitor fail?
- LRTI Death: Research spanning 80 years confirms for the first time
- The decline of the global antibiotic market is threatening the development of new drugs
China provides free COVID-19 vaccines for all citizens!
China provides free COVID-19 vaccines for all citizens!. Free for all citizens! China first new coronavirus vaccine is approved conditionally, providing confidence for the global fight against the epidemic.
Xinhua News Agency, Beijing, December 31 (Reporters Chen Fang and Dong Ruifeng) China has taken a crucial step in the fight against the COVID-19 pneumonia epidemic! The Joint Prevention and Control Mechanism of the State Council released on the 31st that the new coronavirus inactivated vaccine of Sinopharm China Biologics has been approved by the State Food and Drug Administration for conditional listing, and its protective effect meets the relevant standards of the World Health Organization and the State Food and Drug Administration. It will be free for all in the future provide.
“Don’t relax for a moment! This hard-won achievement is the crystallization of the wisdom and sweat of our country’s scientific and technological workers, thanks to the collaborative research of multiple parties.” According to Xu Nanping, the deputy minister of science and technology, there are currently 3 technical routes5 Each vaccine has entered phase III clinical trials. China’s vaccine research and development has always adhered to the people-centered approach and is committed to developing safe, effective and accessible vaccines.
The State Food and Drug Administration of China approved the conditional listing of the vaccine on the 30th. According to Chen Shifei, deputy director of the China National Medical Products Administration, after a series of strict review, review, verification, inspection and data analysis in accordance with the law and procedures, it is believed that the known and potential benefits of the vaccine outweigh the known and potential risks. Meet the pre-set conditional listing standard requirements. Existing data show that the protective efficacy of the above-mentioned vaccine is 79.34%.
According to the relevant laws and regulations of our country, for vaccines urgently needed in response to major public health emergencies, the national drug regulatory authority may conditionally approve registration applications, and at the same time urge companies to continue to complete phase III clinical trials and other post-marketing studies as planned. Many countries around the world have adopted emergency use or conditional listing of new coronavirus vaccines. This is an unprecedented speed in the history of human vaccine development.
“The COVID-19 virus vaccine will be provided free of charge for all.” Zeng Yixin, deputy director of the National Health Commission and head of the vaccine development team of the Joint Prevention and Control Mechanism of the State Council, said that some countries plans to establish an immune barrier for the entire population through vaccination. Based on the ongoing vaccination of high-risk groups and key groups, the elderly and high-risk groups with underlying diseases will be gradually promoted in an orderly manner, followed by general population vaccination.
“It is generally believed that the vaccination rate reaches 60% to 70% in order to establish universal protection.” Zeng Yixin said that in view of the good evidence of the safety and effectiveness of approved vaccines in some countries, the public is encouraged to be active on the premise of informed consent and elimination of contraindications Participate in vaccination.
According to reports, some countries has fully organized and guaranteed the large-scale production of the new coronavirus vaccine, and many companies have successively carried out capacity building.
The launch of China’s COVID-19 virus vaccine injects confidence in the global victory over the epidemic and also provides strong support for vaccines to become a global public product. Prior to this, the United Arab Emirates and Bahrain had separately reviewed and approved the official registration and marketing of SINOPHARM’s China Bio-New Coronavirus vaccine in accordance with the relevant technical standards of the World Health Organization.
(source:internet, reference only)
Disclaimer of medicaltrend.org
